Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' link was removed. This reflects a straightforward release update with a minor UI cleanup.SummaryDifference0.3%
- Check9 days agoChange DetectedThe web page has added significant information regarding drug safety, including specific drug names and locations in Hong Kong and Thailand, while removing various disease-related terms and previous location references.SummaryDifference12%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
- Check52 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or update in the content or functionality.SummaryDifference0.3%
Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.